Overview
Fujirebio develops molecular diagnostic tests for oncology, infectious diseases, neurology, and tissue typing using advanced biomarker detection.
More in Clinical Diagnostics
Company details
Category
🏥 Clinical Diagnostics
Location
Minato, Tokyo, Japan
Funding
$194,700,000
Website
fujirebio.comListed
2026-06-23
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →